Center-Authored Papers

Filters: Author is Way, Sing Sing  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Animals
CD8-Positive T-Lymphocytes
Center-Authored Paper
Florescu DF, Pergam SA, Neely MN, Qiu F, Johnston C, Way SS, Sande J, Lewinsohn DA, Guzman-Cottrill JA, Graham ML et al..  2011.  Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(5):731-738. Abstract
Clinical Research Division
Florescu DF, Pergam SA, Neely MN, Qiu F, Johnston C, Way SS, Sande J, Lewinsohn DA, Guzman-Cottrill JA, Graham ML et al..  2011.  Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(5):731-738. Abstract
e-pub
Florescu DF, Pergam SA, Neely MN, Qiu F, Johnston C, Way SS, Sande J, Lewinsohn DA, Guzman-Cottrill JA, Graham ML et al..  2011.  Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(5):731-738. Abstract
Female
Herpes Genitalis
Herpes Simplex Virus Vaccines
Herpesvirus 2, Human
Immunodominant Epitopes
Injections, Intravenous
Listeria monocytogenes
MICE
Mice, Inbred C57BL
November 2011
Florescu DF, Pergam SA, Neely MN, Qiu F, Johnston C, Way SS, Sande J, Lewinsohn DA, Guzman-Cottrill JA, Graham ML et al..  2011.  Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(5):731-738. Abstract
Recombination, Genetic
Simplexvirus
T-Cell Antigen Receptor Specificity
Vaccination
Vaccine and Infectious Disease Institute
Vaccines, Synthetic
Viral Envelope Proteins